MAGEA1 and non-small cell lung carcinoma: To access the levels of circulating TAA-reactive T cells in NSCLC patients, we performed co-cultures of PBMCs with peptide mixes against four different, highly relevant to NSCLC, TAAs called TERT, MAGEA1, Survivin, and NY-ESO-1.